A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease

Clinical trial NCT00072943 · COMPLETED

Trial details

NCT number: NCT00072943
Sponsor: Facet Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease Colitis Intestinal Disease Gastrointestinal Disease Digestive System Disease

Start date: 2002-03-01
Primary completion: 2004-04-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.